Value Bridge — FRANCISCAN HEALTH LAFAYETTE
Current $10M → Target $19M (+$8.3M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$10.2M
Current EBITDA
$18.5M
Target EBITDA
+$8.3M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$1.9M
Payer Mix Optimization
$4.5M
Cost to Collect Reduction
$1.5M
Clean Claim Improvement
$1.1M
Volume & Rate Growth
$7.6M
What This Means
The 7-lever model projects a 82% EBITDA uplift from $10M to $19M. The highest-impact lever is Volume & Rate Growth at $3.0M probability-weighted.
IC talking point: "We see $8M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $92M in equity value creation."